The Hypovax consortium (www.hypovax.org) has been established at Leiden University Medical Center (LUMC) in The Netherlands to address the recognized challenge of differences in vaccine immunogenicity and efficacy between countries, and between populations within countries.
UVRI, which started the research project in 2016, says it is in the process of returning the mosquito species from a US laboratory.
https://www.monitor.co.ug/uganda/news/national/scientists-move-to-breed-...
The Monitoring Training course was held from 28th August to 1st September 2023 at Uganda Virus Research Institute- International AIDS Vaccine Initiative premises. It aimed at equipping participants with comprehensive insights into effective monitoring practices within the context of clinical research.
The global community has failed to reduce the rate of infection among teenagers at the same rate as infection among adults despite Fast-Track targets to terminate the AIDS epidemic by 2030. In actuality, the rate of progress is three times slower. AIDS is the number one killer of people in this age range in several regions of the world, including sub-Saharan Africa (UNICEF 2019).
A novel trial that has been described as "the last roll of the dice" for a generation of HIV vaccines has entered its latter stages.
Called PrEPVacc, the trial is testing two vaccines alongside two forms of pre-exposure prophylaxis (PrEP) to test vaccine efficacy while offering protection to prevent the spread of HIV.
This year’s Joep Lange Chair and Fellows Symposium is Professor Sharifah Sekalala who will talk about ‘An Analysis of Legal Issues Relating to Digital Health Surveillance and Innovation’.
Every 20th of August 2023, Uganda joins the rest of the world in commemoration of the world Mosquito Day. This day is set aside to recognise the momentous discovery of the link between humans, malaria and mosquitoes by a British doctor Sir Ronald Ross in 1897.
The Francis Crick Institute has just announced a new round of fellowships in the Crick Africa Network.
